What is Alumis Inc.'s D&A?

Alumis Inc. (ALMS) reported D&A of $871K in Q1 2026.

How has Alumis Inc.'s D&A changed year-over-year?

Alumis Inc.'s D&A increased by 3.3% year-over-year, from $843K to $871K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Alumis Inc. ALMS D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.3%

AmgenAMGN

$1.12B-19.5%

Oruka Therapeutics, Inc.ORKA

$43K+169%

ANI PharmaceuticalsANIP

$20.92M-8.6%

Celldex TherapeuticsCLDX

$854K-1.5%

ImmunomeIMNM

$603K-1.3%

Other financials

Income statement

See full

Revenue$1.7M-90.0%

Operating income-$98.4M+3.1%

Net income-$93.1M+6.0%

EPS (diluted)-$0.74+59.3%

Balance sheet

See full

Cash & equivalents$63.9M-50.3%

Total debt$35.7M+1,881%

Total equity$567.0M+237%

Total assets$671.6M+157%

Cash flow

See full

Operating cash flow-$87.1M-8.4%

CapEx$164.0K+343%

Free cash flow-$87.2M-8.5%

Valuation

See full

Market cap$3.17B+739%

Profitability

See full

Operating margin-5,364%—

Net margin-2,825.7%—

FCF margin-4,487.4%—

Returns & leverage

See full

Return on equity-64.6%—

Debt / equity0.1×+0.1×

Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alumis Inc.'s D&A?: Alumis Inc. (ALMS) reported D&A of $871K in Q1 2026.
How has Alumis Inc.'s D&A changed year-over-year?: Alumis Inc.'s D&A increased by 3.3% year-over-year, from $843K to $871K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.